The labeling for Trulicity (dulaglutide; Eli Lilly) has been updated to include use in combination with basal insulin for adults with type 2 diabetes, following approval from the Food and Drug ...

Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise The single-dose pen does not require mixing nor ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy in Provo (Reuters) - Eli ...

Eli Lilly has revealed that it has now received approval from the U.S. Food and Drug Administration (FDA) for two additional doses of Trulicity (dulaglutide). Shares of Eli Lilly closed 1.3% higher on ...

Eli Lilly and Company (LLY) received good news when the FDA approved its new injectable diabetes treatment, Trulicity, for adults suffering from type II diabetes. Trulicity, a glucagon-like peptide-1 ...

The approval was based on data from the randomized, double-blind, parallel-arm phase 3 AWARD-11 trial. The Food and Drug Administration (FDA) has approved 2 additional dosage strengths of Trulicity ® ...

(The Hill) – The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications ...